Johnson Controls International heads into September with a clear tension: the stock has given back 5% over the past month to $139.25, yet the Street keeps lifting its sights.
Morgan Stanley's Chris Snyder moved this week — raising his price target to $180 from $175 while holding an Overweight rating — and he is not alone. Bernstein lifted to $190 from $173 in mid-August. The analyst consensus now sits at a mean target of $163.37, roughly 17% above where the stock is trading. Bulls point to expanding commercial HVAC margins, pricing power, and the sharper focus that followed the divestiture of the residential HVAC business. Bears acknowledge the long-term growth story but argue the stock was already pricing in much of it — EV/EBITDA running near 18.6x and a P/E around 24.9x leave limited room for disappointment, with JCI at the premium end of its building-products peer group. The forward EPS momentum factor score sits at 64 over 30 days and 70 over 90 days, suggesting earnings revisions have been quietly grinding higher — which helps explain why analysts keep nudging targets upward even as the stock softens.
Short interest is not the story here. At 1.67% of the free float — down 6.5% on the week to around 10.2 million shares — bearish conviction is limited. Borrow availability is essentially unconstrained, with shares available to lend running at roughly 60 times the total short position; there is no squeeze dynamic in play. Cost to borrow is 0.38%, a touch higher than a month ago but still negligible. The ORTEX short score has drifted in a narrow range around 31 over the past two weeks — low and stable, reinforcing that this is not a stock where the lending market is generating any signal worth following. Options tell a mildly cautious story, with the put/call ratio at 0.63, modestly above its 20-day average of 0.57 — about one standard deviation elevated. That is not a dramatic hedge, more a slight tilt toward protection after a softer month for the price.
The ownership picture is orderly and well-flagged. Dodge & Cox holds roughly 9.2% of shares — its latest 13G/A amendment in May showed the stake slipping from 10.7% to 9.4%, a trim but still the largest declared position. BlackRock moved the other way, amending its 13G to disclose a stake climbing from 6.7% to 7.8% as of late July. No 13D activist is on the register, and the disclosure caveat applies: these positions are as-last-disclosed around the 5% threshold, and moves below that level may not be reported. Insider data is stale — the most recent EDGAR filings are from January 2026, too dated to carry weight in this note.
Q3 results from late July showed the stock could move meaningfully on a beat: JCI gained 2.6% on the day and extended that to nearly 9.5% over the subsequent five trading sessions. The next scheduled print is November 6. Between now and then, the distance between the current price and the analyst consensus — and whether a soft macro backdrop bites into commercial construction activity — is the central question worth tracking.
See the live data behind this article on ORTEX.
Open JCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
